Christa Pike was supposed to die at 10 a.m. on September 30, 2026, at Riverbend Maximum Security Institution in Nashville. She would have been the first woman executed in Tennessee in more than two centuries, and the only woman on the state's death row, condemned for the 1995 murder of Colleen Slemmer. A federal appeals panel briefly blocked the execution over her lawyers' arguments about her history of abuse and physically small veins that would make an intravenous line difficult to place. The Supreme Court overturned that stay in a 6-3 vote. What followed, according to multiple media witnesses, was not a clean procedure. Tennessee's protocol calls for two 50 milliliter syringes of pentobarbital. Pike received both. Witnesses reported hearing her breathing, even snoring, behind a curtain that officials drew to hide what was happening. A witness to the scene said the attempt had 'went really poorly.' She was still alive hours later and was taken to a hospital for treatment, not a coroner. This was not Tennessee's first stumble this year. In May 2026, the state aborted the execution of Tony Carruthers after the execution team spent roughly an hour failing to find a usable vein, with a witness describing a staff member's hands shaking as he tried to thread a needle into the condemned man's chest. Subsequent reporting found that Tennessee's current lethal injection protocol, adopted in 2025, appears to include reduced training requirements in intravenous line placement compared with earlier versions, a detail that surfaced in court filings after the Carruthers failure. Tony Carruthers' attorney, Maria DeLiberato, was present for that attempt. Two failures within five months, in the same state, both traced back to the same basic task of getting a needle correctly into a vein, is not an outlier run of bad luck. It looks like a system that never had the margin for error it pretended to. Governor Bill Lee has now halted the state's remaining executions scheduled for 2026 and ordered a comprehensive third-party review. A death penalty researcher cited in national coverage of the Pike case called the failure unprecedented. Nationally, the method remains dominant: of the people executed in the United States in 2025, the overwhelming majority died by lethal injection, with a handful executed by nitrogen hypoxia, a newer method pioneered in Alabama. Every execution carried out in the country so far in 2026 has been by lethal injection. In other words, this is still how America kills the people it has sentenced to die, and the mechanics of that killing are handled by people with nothing like the training the task demands. Compare that to what happens when a family puts a dying dog to sleep. Veterinary euthanasia is performed by a licensed veterinarian, someone who has completed years of professional education, who is trained specifically in vascular access, sedation, dosing by body weight, and recognising when a line has failed. Professional veterinary standards exist precisely to make sure the drug goes into a vein and does its job quickly and without pain. A failed line in a veterinary clinic is caught immediately, because the person holding the syringe has the clinical training to notice the signs: swelling, resistance, the animal's reaction. A prison execution team, by contrast, is typically composed of correctional staff with no medical license and, as Tennessee's own recent record shows, apparently not even consistent training in a procedure as basic as cannulation. The reason trained medical professionals are not the ones holding the syringe in a death chamber is not bureaucratic oversight. It is a deliberate, decades-old ethical wall. The American Medical Association's Code of Medical Ethics explicitly bars physicians from selecting injection sites for lethal injection executions, and the AMA has for decades opposed physician involvement in capital punishment entirely. Medical and emergency-response professional bodies, including the National Association of Emergency Medical Technicians, have said outright that participation in executions violates the ethics of their professions. A doctor who inserted that IV or pushed that plunger would risk their license. A doctor is not even permitted to be the one who declares the prisoner dead in many jurisdictions, because doing so would implicate the practice of medicine in an act medicine's own governing bodies consider incompatible with the Hippocratic oath to do no harm. That leaves the actual task, inserting a line into a human vein under time pressure, with cameras and lawyers and a clock running, to whoever the department of corrections can find. There is a parallel track in American medicine that shows what this could look like if doctors were actually involved, and it looks nothing like a death chamber. A number of states permit medical aid in dying, often under titles like Death with Dignity, beginning with Oregon's pioneering law. These statutes apply only to mentally competent, terminally ill adults who request the medication themselves, require waiting periods and multiple physician confirmations, and in most cases require the patient to self-administer the drug. A doctor's role is to prescribe under strict safeguards built around consent and the reduction of suffering, not to be the hand on the plunger in a procedure the patient has no say in and cannot stop. The contrast with a death chamber, where the person who will die has no say in dosage, timing, or method, and where the person administering the drug may never have placed an IV line outside a training exercise, is about as stark as it gets. There is also a less obvious reason prison officials are left scrambling with inexperienced hands: the drug supply itself. For more than a decade, pharmaceutical manufacturers, including major European firms, have refused to sell their products for use in executions, citing ethical objections, and have tightened distribution controls specifically to keep their drugs out of death chambers. That refusal pushed states toward compounding pharmacies operating with far less regulatory scrutiny, toward secrecy laws shielding drug sources from public and legal challenge, and toward improvised protocols nobody in the pharmaceutical industry ever validated for this purpose. States are not just short on trained hands. They are short on a reliable, quality-controlled drug supply, because the people who make these medications for a living have refused, as a matter of professional ethics, to let their product be used this way.